Compare IXHL & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | IXHL | BGX |
|---|---|---|
| Founded | 2001 | 2010 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.7M | 151.0M |
| IPO Year | N/A | N/A |
| Metric | IXHL | BGX |
|---|---|---|
| Price | $0.36 | $11.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.5M | 67.9K |
| Earning Date | 02-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.08 | $10.69 |
| 52 Week High | $2.25 | $12.44 |
| Indicator | IXHL | BGX |
|---|---|---|
| Relative Strength Index (RSI) | 40.72 | 46.19 |
| Support Level | $0.34 | $11.62 |
| Resistance Level | $0.42 | $11.75 |
| Average True Range (ATR) | 0.02 | 0.08 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 21.16 | 56.14 |
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.